CLOV vs PAHC · rev $1.37B vs P/E 13, rev $1.30B
Clover Health Investments Corp (CLOV) versus Phibro Animal Health Corporation (PAHC) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Phibro Animal Health Corporation (PAHC) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported PAHC revenue for 2025-06-30 was $1.30B. Net income was $48.3M. Revenue was up 27.4% from 2024-06-30 to 2025-06-30. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
CLOV currently screens at market cap $1.55B. PAHC currently screens at market cap $1.25B and trailing P/E 13.2.
Not investment advice. Open the CLOV and PAHC stock pages for the full models.
Not investment advice.